As of December 2024 Adaptimmune Therapeutics has a market cap of $0.15 Billion USD. This makes Adaptimmune Therapeutics the world's 8446th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 22nd, 2024 the market cap of Adaptimmune Therapeutics was reported to be: